Post Marketing Surveillance in Japan on Drug Use of JARDIANCE® Tablets in Elderly Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Empagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 10 Feb 2017 Status changed from active, no longer recruiting to completed.
- 06 Sep 2016 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016.
- 06 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Sep 2016.